Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Non-Current Deffered Revenue (2018 - 2025)

Health Catalyst's Non-Current Deffered Revenue history spans 8 years, with the latest figure at $410000.0 for Q4 2025.

  • For Q4 2025, Non-Current Deffered Revenue rose 64.66% year-over-year to $410000.0; the TTM value through Dec 2025 reached $410000.0, up 64.66%, while the annual FY2025 figure was $410000.0, 64.66% up from the prior year.
  • Non-Current Deffered Revenue reached $410000.0 in Q4 2025 per HCAT's latest filing, up from $385000.0 in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $1.1 million in Q1 2021 to a low of $51000.0 in Q2 2024.
  • Average Non-Current Deffered Revenue over 5 years is $426750.0, with a median of $322000.0 recorded in 2022.
  • Peak YoY movement for Non-Current Deffered Revenue: crashed 88.7% in 2022, then soared 545.1% in 2025.
  • A 5-year view of Non-Current Deffered Revenue shows it stood at $929000.0 in 2021, then plummeted by 88.7% to $105000.0 in 2022, then decreased by 26.67% to $77000.0 in 2023, then skyrocketed by 223.38% to $249000.0 in 2024, then soared by 64.66% to $410000.0 in 2025.
  • Per Business Quant, the three most recent readings for HCAT's Non-Current Deffered Revenue are $410000.0 (Q4 2025), $385000.0 (Q3 2025), and $329000.0 (Q2 2025).